Cargando…
Impact of pharmacogenetics on aspirin resistance: a systematic review
Background Pharmacogenetics promises better control of diseases such as cardiovascular disease (CVD). Acetylsalicylic acid, aspirin, prevents the formation of an activating agent of platelet aggregation and vasoconstriction, and it is used to prevent CVD. Nevertheless, patients may have treatment f...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Thieme Revinter Publicações Ltda.
2023
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014202/ https://www.ncbi.nlm.nih.gov/pubmed/36918009 http://dx.doi.org/10.1055/s-0042-1758445 |